Normothermic machine perfusion

1 paper2 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

1 lab in 1 country

Animals1

Outcomes

Ex situ liver preservation

upin human cells1upin pigs1

1 study

Normothermic machine perfusion improves ex situ liver preservation in human cells (7-day preservation in 4 livers; controls deteriorated after 66 [48–84] hours).
CellsNontransplantable human donor liversLong-term ex situ liver preservation protocol using OrganOx Metraliver7 daysn = 4
Establishing a Platform for 1-Wk Normothermic Machine Perfusion of Donor Livers
Transplantation1 Oct 2026
Normothermic machine perfusion improves ex situ liver preservation in pigs (7-day perfusion with stable function and preserved morphology).
AnimalsEx situ porcine liver perfusionLong-term ex situ liver preservation protocol using OrganOx Metraliver7 days
Establishing a Platform for 1-Wk Normothermic Machine Perfusion of Donor Livers
Transplantation1 Oct 2026

Latest

1 in 12 months

Transplantation2 Oct

Establishing a Platform for 1-Wk Normothermic Machine Perfusion of Donor Livers

Experiments in animalsInterventions

Paper

Normothermic machine perfusion

Outcomes

Latest

Establishing a Platform for 1-Wk Normothermic Machine Perfusion of Donor Livers

Related